Psyched Wellness Submits a Provisional Patent Application For AME-1
Toronto, Ontario--(Newsfile Corp. - March 17, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has submitted a provisional patent application with the United States Patent and Trademark office, to cover the Company's unique extraction processes for its proprietary Amanita muscaria extract AME-1....
2021-03-17 4:00 AM EDT
Psyched Wellness Announces Changes to the Board of Directors
Toronto, Ontario--(Newsfile Corp. - March 15, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Janeen Stodulski has been appointed as a director of the Corporation. Psyched also announced that Chris Hazelton has resigned as a director of the Corporation. CEO Jeff Stevens commented that, "Chris stayed...
2021-03-15 5:04 PM EDT
Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1
Toronto, Ontario--(Newsfile Corp. - March 2, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has received the results from its Maximum Tolerated Dosage (MTD) study conducted by KGK Science, a licensed CRO in Canada. "I am pleased to share the positive results from the individual studies that...
2021-03-02 3:00 AM EST
Psyched Wellness Closes $6,603,000 Bought Deal Private Placement
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that further to its press releases dated January 21, 2021 and January 22, 2021, it has closed the bought deal private placement for total gross proceeds of $6,603,000 (the "Offering"). In connection with the Offering, the...
2021-02-17 9:59 AM EST
Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol
Toronto, Ontario--(Newsfile Corp. - February 4, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share an update on the previously announced study to determine the therapeutic values of muscimol for antioxidant and anti-inflammatory purposes via a nerve derived immunity and neuroprotective modulation models. The...
2021-02-04 3:00 AM EST
Psyched Wellness to Participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference
Toronto, Ontario--(Newsfile Corp. - February 2, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushroom derived products, is pleased to announce its CEO and COO will be presenting at Canaccord Genuity Group Inc.'s upcoming conference; New Paradigms and Treatment Approaches in Mental Health. Psyched Wellness CEO, Jeff Stevens and COO,...
2021-02-02 12:24 PM EST
Psyched Wellness Included in First Psychedelic Exchange Traded Fund
Toronto, Ontario--(Newsfile Corp. - January 26, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is one of the 17 companies in the United States and Canada that will be included in the first psychedelic exchange-traded fund, which is managed by Horizons ETF Management. The Horizons Psychedelic Stock Index ETF index is expected to...
2021-01-26 3:00 AM EST
Psyched Wellness to Present at Inaugural KCSA Psychedelics Investor Conference
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it is participating in the Psychedelic Investor Conference, hosted by KCSA Strategic Communications on Tuesday, January 26th. Jeff Stevens, CEO of the Company will be presenting Psyched Wellness at 10:35 am...
2021-01-25 11:02 AM EST
Re-Release: Psyched Wellness Upsizes Previously Announced Bought Deal Offering
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has agreed to increase the size of its previously announced bought deal private placement led by Canaccord Genuity Corp. (the "Lead Underwriter"). The Lead Underwriter has agreed, on behalf of a...
2021-01-25 3:00 AM EST
Psyched Wellness Submits an Application to Register a Trademark for the Company's Unique Extraction
Toronto, Ontario--(Newsfile Corp. - January 21, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has submitted an application with the United States Patent and Trademark Office (USPTO) to register the trademark "AME-1" in connection with the Company's unique extraction. AME-1, which stands for...
2021-01-21 3:00 AM EST
Psyched Wellness Announces New OTCQB Ticker: PSYCF
Toronto, Ontario--(Newsfile Corp. - January 19, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (formerly Duncan Park Holdings Corporation) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that FINRA accepted its proposed symbol change for the OTCQB market from the former DCNPF to PSYCF. The Company's shares have commenced trading in the US markets under...
2021-01-19 3:00 AM EST
Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol
Toronto, Ontario--(Newsfile Corp. - January 14, 2021) - Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has completed the first step in identifying the medicinal potential of Muscimol for various mental and physical health issues. The research was led by Psyched...
2021-01-14 3:00 AM EST
Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol
Toronto, Ontario--(Newsfile Corp. - January 6, 2021) - Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has commenced a study to determine the therapeutic values of muscimol for antioxidant and anti-inflammatory purposes via a nerve derived immunity and...
2021-01-06 3:00 AM EST
Psyched Wellness Has Commenced Research on Muscimol for Various Ailments
Toronto, Ontario--(Newsfile Corp. - December 28, 2020) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (formerly Duncan Park Holdings Corporation) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has commenced research on Muscimol for various ailments, with a focus on mental health issues. The research is led by Psyched Wellness's board member, Prof....
2020-12-28 7:00 AM EST
Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria
Toronto, Ontario--(Newsfile Corp. - December 23, 2020) - Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has shipped its first batch of Amanita Muscaria extract to its CRO partner to commence the Pre-Clinical trials. The Company sent 108 grams of highly concentrated...
2020-12-23 3:00 AM EST
Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom
Toronto, Ontario--(Newsfile Corp. - December 15, 2020) - Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has successfully completed its first extraction of a legal psychedelic derived from Amanita Muscaria mushrooms. The scientific team sourced dried Amanita...
2020-12-15 3:00 AM EST
Psyched Wellness Successfully Completes Writing the Final Extraction Protocol, the Assembly of Safety & Efficacy Narratives, and Writing the Safety Data Sheet (SDS) for Its First Product
Toronto, Ontario--(Newsfile Corp. - December 10, 2020) - Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has successfully completed a comprehensive process of lab experiments which have determined the Company's final extraction protocol, that will be used for the...
2020-12-10 3:00 AM EST
Psyched Wellness Advisor Kevin Feeney Releases Book on Amanita Muscaria
Toronto, Ontario--(Newsfile Corp. - December 9, 2020) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (formerly Duncan Park Holdings Corporation) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share a link to the newly published volume on Amanita Muscaria by our advisor, Kevin Feeney. The book is titled, "Fly Agaric: A Compendium of History, Pharmacology, Mythology,...
2020-12-09 12:00 PM EST
Psyched Wellness Ltd. Adds Aaron Slater to the Advisory Board
Toronto, Ontario--(Newsfile Corp. - December 8, 2020) - Psyched Wellness Ltd. (CSE:PSYC) (OTCQB: DCNPF) (formerly Duncan Park Holdings Corporation) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Aaron Slater has joined the advisory board of the Company to work with the team on exploring new markets for its products and identifying possible M&A opportunities. "I have...
2020-12-08 1:00 AM EST
Psyched Wellness Announces Positive Toxicology Assessment and Provides Path to Market for a Legal Psychedelic Mushroom Product
Toronto, Ontario--(Newsfile Corp. - December 7, 2020) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (formerly Duncan Park Holdings Corporation) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to provide the highlights from the toxicology assessment conducted by KGK Sciences (the "Toxicology Assessment"), a Canadian contract research organization. The Toxicology...
2020-12-07 4:00 AM EST